HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incidence of spontaneous abortion in clomiphene pregnancies.

Abstract
The purpose of this study was to determine whether the use of clomiphene results in a higher incidence of spontaneous abortion than occurs naturally in subfertile patients. Reproductive outcomes of 1744 clomiphene pregnancies were compared to outcomes of 3245 spontaneous pregnancies in a prospective study. Abortion was classified as clinical if a sac was seen on ultrasound or if it occurred after 6 gestational weeks, and as preclinical if a quantitative human chorionic gonadotrophin (HCG) was > or = 25 mIU and no sac was seen or abortion occurred earlier. The overall incidence of abortion was higher for clomiphene pregnancies (23.7%), compared with spontaneous pregnancies (20.4%) (P < 0.01). Preclinical abortions were increased by clomiphene for all ages (5.8 versus 3.9%, P < 0.01) and for age > or = 30 years (8.0 versus 4.9%, P < 0.001), but not for age < 30 years (3.7 versus 3.0%). Clinical abortions were increased by clomiphene for age < 30 years (15.9 versus 11.2%) (P < 0.01), but not for age > or = 30 years (20.1 versus 22.3%) or all ages (18.0 versus 16.4%). Clinical abortions occurred 22% less often following clomiphene compared with spontaneous pregnancies for patients with luteal insufficiency (18.3 versus 23.6%, P < 0.05). We conclude that the increase in abortion due to clomiphene is small and may be related to different causes for women aged < 30 and > or = 30 years, and also that clomiphene may decrease clinical abortions in patients with luteal insufficiency.
AuthorsR P Dickey, S N Taylor, D N Curole, P H Rye, R Pyrzak
JournalHuman reproduction (Oxford, England) (Hum Reprod) Vol. 11 Issue 12 Pg. 2623-8 (Dec 1996) ISSN: 0268-1161 [Print] England
PMID9021363 (Publication Type: Journal Article)
Chemical References
  • Clomiphene
  • Menotropins
  • Follicle Stimulating Hormone
Topics
  • Abortion, Spontaneous (etiology)
  • Adult
  • Clomiphene (adverse effects, therapeutic use)
  • Female
  • Fertilization in Vitro
  • Follicle Stimulating Hormone (therapeutic use)
  • Gamete Intrafallopian Transfer
  • Gestational Age
  • Humans
  • Menotropins (therapeutic use)
  • Pregnancy
  • Pregnancy Outcome
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: